Stranger than fiction.

Catch up on his thinking on the hottest topics of the past week.

The fallout from Bear Stearns’ bailout, shorting Buffett, and more.

Shame on FT for repeating the company line — and for getting a bad case of amnesia.

Not all mutual fund sponsors, brokers and other financial advisers have cleaned up their act.

Bear Stearns’ fall and persistent credit woes point to more Fed rate cuts next week.

Biotech funds dominate the best-performing list for the week.